Literature DB >> 21450694

Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes.

Pedro Melgar-Lesmes1, Montserrat Pauta, Vedrana Reichenbach, Gregori Casals, Josefa Ros, Ramon Bataller, Manuel Morales-Ruiz, Wladimiro Jiménez.   

Abstract

BACKGROUND: The activation of the apelin receptor (APJ) plays a major role in both angiogenic and fibrogenic response to chronic liver injury. However, the mechanisms that govern the induction of APJ expression have not been clarified so far.
METHODS: The regulation and the role of APJ in cultured human liver cells were investigated. Tissular expression of APJ and α-smooth muscle actin was analysed by immunocolocalisation in human cirrhotic liver and in control samples. mRNA and protein expression of APJ were analysed in two cell lines, LX-2 (as hepatic stellate cells, HSCs) and HepG2 (as hepatocytes), under hypoxic conditions or after exposure to proinflammatory or profibrogenic factors. Additionally, both hepatic cell lines were stimulated with apelin to assess cell survival and the expression of angiogenic factors.
RESULTS: The APJ-positive signal was negligible in control livers. In contrast, APJ was highly expressed in HSCs and slightly expressed in hepatocytes of human cirrhotic liver. Sustained hypoxia and lipopolysaccharide stimulated the expression of APJ in LX-2 cells. Moreover, hypoxia, tumour necrosis factor α and angiotensin II induced the expression of APJ in HepG2 cells. Activation of APJ stimulated angiopoietin-1 expression and cell survival in LX-2 cells and, in turn, triggered the synthesis of vascular endothelial growth factor type A and platelet-derived growth factor-BB in HepG2 cells.
CONCLUSIONS: These results suggest that hypoxia and inflammatory factors could play a major role in the activation of the hepatic apelin system leading to angiogenic and fibroproliferative response occurring in chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450694     DOI: 10.1136/gut.2010.234690

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth.

Authors:  Chad Hall; Laurent Ehrlich; Julie Venter; April O'Brien; Tori White; Tianhao Zhou; Tien Dang; Fanyin Meng; Pietro Invernizzi; Francesca Bernuzzi; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Cancer Lett       Date:  2016-11-26       Impact factor: 8.679

Review 2.  Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev; Dmitry Vladimirovich Belov
Journal:  World J Hepatol       Date:  2016-06-08

Review 3.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

4.  Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism.

Authors:  Chantal Bertrand; Jean-Philippe Pradère; Nancy Geoffre; Simon Deleruyelle; Bernard Masri; Jean Personnaz; Sophie Le Gonidec; Aurélie Batut; Katie Louche; Cédric Moro; Philippe Valet; Isabelle Castan-Laurell
Journal:  Endocrine       Date:  2018-02-01       Impact factor: 3.633

5.  The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.

Authors:  Pinelopi P Kapitsinou; Ganeshkumar Rajendran; Lindsay Astleford; Mark Michael; Michael P Schonfeld; Timothy Fields; Sheila Shay; Jaketa L French; James West; Volker H Haase
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

6.  Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.

Authors:  Rola M Farid; Riham M Abu-Zeid; Ahmed El-Tawil
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Cardiovascular response to small-molecule APJ activation.

Authors:  Brandon Ason; Yinhong Chen; Qi Guo; Kimberly M Hoagland; Ray W Chui; Mark Fielden; Weston Sutherland; Rhonda Chen; Ying Zhang; Shirley Mihardja; Xiaochuan Ma; Xun Li; Yaping Sun; Dongming Liu; Khanh Nguyen; Jinghong Wang; Ning Li; Sridharan Rajamani; Yusheng Qu; BaoXi Gao; Andrea Boden; Vishnu Chintalgattu; Jim R Turk; Joyce Chan; Liaoyuan A Hu; Paul Dransfield; Jonathan Houze; Jingman Wong; Ji Ma; Vatee Pattaropong; Murielle M Véniant; Hugo M Vargas; Gayathri Swaminath; Aarif Y Khakoo
Journal:  JCI Insight       Date:  2020-04-23

8.  Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.

Authors:  Lucie Geurts; Vladimir Lazarevic; Muriel Derrien; Amandine Everard; Marie Van Roye; Claude Knauf; Philippe Valet; Myriam Girard; Giulio G Muccioli; Patrice François; Willem M de Vos; Jacques Schrenzel; Nathalie M Delzenne; Patrice D Cani
Journal:  Front Microbiol       Date:  2011-07-13       Impact factor: 5.640

9.  Apelin and pulmonary hypertension.

Authors:  Charlotte U Andersen; Ole Hilberg; Søren Mellemkjær; Jens E Nielsen-Kudsk; U Simonsen
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

10.  Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.

Authors:  Peng-Yuan Zhuang; Jun Shen; Xiao-Dong Zhu; Lu Lu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.